Related references
Note: Only part of the references are listed.Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes
Ryuji Kato et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Immunology in the liver - from homeostasis to disease
Felix Heymann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
A novel cell-based assay for the evaluation of immune-and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury
Shingo Oda et al.
TOXICOLOGY LETTERS (2016)
Endoplasmic Reticulum Stress in Immunity
Sarah E. Bettigole et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury
Alastair Mak et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4
Alastair Mak et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Treatment of PD-1-/- Mice With Amodiaquine and Anti-CTLA4 Leads to Liver Injury Similar to Idiosyncratic Liver Injury in Patients
Imir G. Metushi et al.
HEPATOLOGY (2015)
Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment
Mala Chakraborty et al.
HEPATOLOGY (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Inflammasome activation and function in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Activation of Inflammasomes by Agents Causing Idiosyncratic Skin Reactions: A Possible Biomarker
J. Kyle Weston et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Clozapine Promotes the Proliferation of Granulocyte Progenitors in the Bone Marrow Leading to Increased Granulopoiesis and Neutrophilia in Rats
Alexandra R. Lobach et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Evolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges
John R. Senior
DRUG SAFETY (2014)
Drug-Induced Liver Injury and Drug Development: Industry Perspective
Arie Regev
SEMINARS IN LIVER DISEASE (2014)
Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development
Ryan E. Morgan et al.
TOXICOLOGICAL SCIENCES (2010)
A peroxisome proliferator-activated receptor-γ agonist, troglitazone, facilitates caspase-8 and-9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells
Y Akasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats
JP Luyendyk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration:: A comparative study in the rat
M Forsberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Tolcapone-related liver dysfunction - Implications for use in Parkinson's disease therapy
N Borges
DRUG SAFETY (2003)
Different toxicological profile of two COMT inhibitors in vivo:: the role of uncoupling effects
K Haasio et al.
JOURNAL OF NEURAL TRANSMISSION (2002)